Evidence map›Paper›PMID 35253976›Full record

ArticleJournal of thrombosis and haemostasis : JTH2022

Effects of ex vivo blood anticoagulation and preanalytical processing time on the proteome content of platelets.

Samuel Tassi Yunga, Austin J Gower, Alexander R Melrose, Meghan K Fitzgerald, Ashmitha Rajendran, Theresa A Lusardi, Randall J Armstrong, Jessica Minnier, Kelley R Jordan, Owen J T McCarty and 4 more

Open access · greenAbstract read
In one paragraph

Article in Journal of thrombosis and haemostasis : JTH, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 2 pooled it
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 2 syntheses or guidelines pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Samuel Tassi YungaCancer Early Detection Advanced Research Center (CEDAR), Knight Cancer Institute, School of Medicine, Oregon Health & Science University, Portland, Oregon, USA.ORCID 0000-0003-3631-2156
Austin J GowerCancer Early Detection Advanced Research Center (CEDAR), Knight Cancer Institute, School of Medicine, Oregon Health & Science University, Portland, Oregon, USA.
Alexander R MelroseDivision of Cardiology, Knight Cardiovascular Institute, School of Medicine, Oregon Health & Science University, Portland, Oregon, USA.
Meghan K FitzgeraldCancer Early Detection Advanced Research Center (CEDAR), Knight Cancer Institute, School of Medicine, Oregon Health & Science University, Portland, Oregon, USA.
Ashmitha RajendranCancer Early Detection Advanced Research Center (CEDAR), Knight Cancer Institute, School of Medicine, Oregon Health & Science University, Portland, Oregon, USA.
Theresa A LusardiCancer Early Detection Advanced Research Center (CEDAR), Knight Cancer Institute, School of Medicine, Oregon Health & Science University, Portland, Oregon, USA.
Randall J ArmstrongCancer Early Detection Advanced Research Center (CEDAR), Knight Cancer Institute, School of Medicine, Oregon Health & Science University, Portland, Oregon, USA.
Jessica MinnierCancer Early Detection Advanced Research Center (CEDAR), Knight Cancer Institute, School of Medicine, Oregon Health & Science University, Portland, Oregon, USA.
Kelley R JordanDepartment of Biomedical Engineering, School of Medicine, Oregon Health & Science University, Portland, Oregon, USA.ORCID 0000-0002-7090-0667
Owen J T McCartyDepartment of Biomedical Engineering, School of Medicine, Oregon Health & Science University, Portland, Oregon, USA.
Larry L DavidProteomics Shared Resource, Oregon Health & Science University, Portland, Oregon, USA.
Phillip A WilmarthProteomics Shared Resource, Oregon Health & Science University, Portland, Oregon, USA.
Ashok P ReddyProteomics Shared Resource, Oregon Health & Science University, Portland, Oregon, USA.
Joseph E AslanDepartment of Biomedical Engineering, School of Medicine, Oregon Health & Science University, Portland, Oregon, USA.ORCID 0000-0002-8873-0387
Oregon Health & Science University · US

Funding

Understanding the origins of rapid recurrence of pancreatic cancer after resectionP30CA069533 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI Grace B Gill · 1997 to 2026
$60.5M
Proteomics CoreP30EY010572 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI Kate E Keller · 1995 to 2026
$19.4M
Characterization of Coagulation Factor-platelet Interactions: Role of FXIR01HL101972 · NHLBI · OREGON HEALTH & SCIENCE UNIVERSITY · PI Owen J McCarty · 2010 to 2026
$8.5M
Pathway Maps of Platelet Phenotype and FunctionR01HL146549 · NHLBI · OREGON HEALTH & SCIENCE UNIVERSITY · PI ASLAN, JOSEPH E · 2019 to 2023
$2.5M
LTQ Orbitrap VelosS10OD012246 · OD · OREGON HEALTH & SCIENCE UNIVERSITY · PI DAVID, LARRY L · 2012 to 2012
$854k
NCI NIH HHS P30 CA069533NCI NIH HHS P30CA069533NEI NIH HHS P30 EY010572NEI NIH HHS P30EY010572NHLBI NIH HHS R01 HL101972NHLBI NIH HHS R01HL101972NHLBI NIH HHS R01 HL146549NHLBI NIH HHS R01HL146549NIH HHS S10 OD012246NIH HHS S10OD-012246
6 · The paper itself

Abstract

backgroundEx vivo assays of platelet function critically inform mechanistic and clinical hematology studies, where effects of divergent blood processing methods on platelet composition are apparent, but unspecified.

objectiveHere, we evaluate how different blood anticoagulation options and processing times affect platelet function and protein content ex vivo.

methodsParallel blood samples were collected from healthy human donors into sodium citrate, acid citrate dextrose, EDTA or heparin, and processed over an extended time course for functional and biochemical experiments, including platelet proteome quantification with multiplexed tandem mass tag (TMT) labeling and triple quadrupole mass spectrometry (MS).

resultsEach anticoagulant had time-dependent effects on platelet function in whole blood. For instance, heparin enhanced platelet agonist reactivity, platelet-monocyte aggregate formation and platelet extracellular vesicle release, while EDTA increased platelet α-granule secretion. Following platelet isolation, TMT-MS quantified 3357 proteins amongst all prepared platelet samples. Altogether, >400 proteins were differentially abundant in platelets isolated from blood processed at 24 h versus 1 h post-phlebotomy, including proteins pertinent to membrane trafficking and exocytosis. Anticoagulant-specific effects on platelet proteomes included increased complement system and decreased α-granule proteins in platelets from EDTA-anticoagulated blood. Platelets prepared from heparinized blood had higher levels of histone and neutrophil-associated proteins in a manner related to neutrophil extracellular trap (NET) formation and platelet:NET interactions in whole blood ex vivo.

conclusionOur results demonstrate that different anticoagulants routinely used for blood collection have varying effects on platelets ex vivo, where methodology-associated alterations in platelet proteome may influence mechanistic, translational and biomarker studies.

Indexed as

Blood PlateletsProteomeAnticoagulantsEdetic AcidHeparinHumansAnticoagulantsEdetic AcidHeparinProteomeanticoagulantsbiomarkersblood plateletsplatelet function testsproteomics

Identifiers

PMID35253976
PMCPMC9887642
OpenAlexW4220946082

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.